239 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
JAZZ Jazz Pharmaceuticals plc $161.01 $9.73B Downtrend
Article Searches
Lakers sink in offensively muddled loss to Jazz https://www.ocregister.com/2019/01/11/lakers-sink-in-offensively-muddled-loss-to-jazz/ Jan 12, 2019 - The Lakers squander an opportunity against a Jazz team playing without all three of its normal point guards and lose 113-95. Donovan Mitchell (33 points, nine assists) leads Utah, while L.A. shoots just 36 percent.
Jazz Pharmaceuticals (JAZZ) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow https://seekingalpha.com/article/4232121-jazz-pharmaceuticals-jazz-presents-37th-annual-j-p-morgan-healthcare-conference-slideshow?source=feed_sector_healthcare Jan 08, 2019 - The following slide deck was published by Jazz Pharmaceuticals, Inc. in conjunction with this event.
3 Big 2019 FDA Decisions And Their Effect On These Biotechs https://seekingalpha.com/article/4231938-3-big-2019-fda-decisions-effect-biotechs?source=feed_sector_healthcare Jan 07, 2019 - Nektar's pain drug NKTR-181 is up for review in May. Upside is triple digits, downside about 60-70%.Merck's Keytruda is up for review in February for melanoma.Jazz JZP-110 for excessive sleepiness is
Jazz Inks Deal with Codiak to Develop Exosome Therapeutics http://www.zacks.com/stock/news/345873/jazz-inks-deal-with-codiak-to-develop-exosome-therapeutics?cid=CS-ZC-FT-345873 Jan 04, 2019 - Jazz (JAZZ) collaborates with Codiak for research, development and commercialization of exosome therapeutics to treat cancer.
Front Yard Residential: Well Positioned Into 2019 https://seekingalpha.com/article/4230606-front-yard-residential-well-positioned-2019?source=feed_all_articles Dec 28, 2018 - Management execution has been stellar in 2018; I expect 2019 will be similar.However, the share price has not moved in tandem. Major shareholders are going to hold management accountable for the share
Jazz (JAZZ) Falls as Sleep Drug Gets Extended Review From FDA http://www.zacks.com/stock/news/344379/jazz-jazz-falls-as-sleep-drug-gets-extended-review-from-fda?cid=CS-ZC-FT-344379 Dec 24, 2018 - Jazz (JAZZ) announces that the FDA has extended the review period of its new drug application for sleep drug, solriamfetol, by three months to Mar 20, 2019.
Jazz (JAZZ) Increases Share Buyback Authorization by $400M http://www.zacks.com/stock/news/342395/jazz-jazz-increases-share-buyback-authorization-by-%24400m?cid=CS-ZC-FT-342395 Dec 11, 2018 - Jazz's (JAZZ) board sanctions a raise in its share buyback authorization by $400 million.
The Daily Biotech Pulse: Management Change At Merck, Jazz Buyback, Arrowhead Earnings http://feeds.benzinga.com/~r/benzinga/~3/VMuLFYyeuTw/the-daily-biotech-pulse-management-change-at-merck-jazz-buyback-arrow Dec 11, 2018 -

Here's a roundup of top developments in the biotech space over the last 24 hours.

Scaling The Peak

(Biotech stocks hitting 52-week highs on Dec. 10)

read more

Why Is Jazz (JAZZ) Up 3% Since Last Earnings Report? http://www.zacks.com/stock/news/341550/why-is-jazz-jazz-up-3-since-last-earnings-report?cid=CS-ZC-FT-341550 Dec 06, 2018 - Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Enrollment underway in late-stage study of Jazz Pharma's JZP-258 in excessive daytime sleepiness https://seekingalpha.com/news/3413144-enrollment-underway-late-stage-study-jazz-pharmas-jzpminus-258-excessive-daytime-sleepiness?source=feed_news_all Nov 29, 2018 - The first patient has been enrolled in a Phase 3 clinical trial evaluating Jazz Pharmaceuticals' (NASDAQ:JAZZ) JZP-258 in patients with idiopathic hypersomnia (excessive daytime sleepiness of unknown

Pages: 123456...24

Page 1>

Related Companies

Name Exchange Price Mkt Cap
PRGO Perrigo Company NYSE $72.57 $9.93B
BGNE BeiGene, Ltd. NASDAQ $159.91 $9.47B
ALNY Alnylam Pharmaceuticals, Inc. NASDAQ $93.43 $9.41B
NKTR Nektar Therapeutics NASDAQ $58.29 $10.05B
SRPT Sarepta Therapeutics, Inc. NASDAQ $152.52 $10.13B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Jazz Pharmaceuticals plc
JAZZ - Google Finance https://www.google.com/finance?q=JAZZ Industry related info and international coverage Summary News
JAZZ - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=JAZZ Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options